Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity
- PMID: 21492058
- DOI: 10.1517/17425247.2011.566552
Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity
Abstract
Introduction: The use of liposomes increases the therapeutic index of many drugs, and also offers drug targeting and controlled release. The commercial impact of liposomes is strengthened by the invention of several active drug encapsulation methods, allowing the encapsulation of several weak base or weak acid drugs with very high drug-to-lipid ratios.
Areas covered: In recent years, there have been reports on several new approaches to retain more hydrophobic drugs inside liposomes, in the circulation. Most of these methods apply drug precipitation inside preformed liposomes, as low soluble complexes with ions or chemicals. In some cases, drug derivatization was applied to enable active encapsulation of hydrophobic drugs, previously not reported to encapsulate, by active or remote loading. This review presents and compares most of the existing methods of active drug encapsulation and outlines recent strategies to achieve stable drug encapsulation in vivo.
Expert opinion: At present, there is no single universal encapsulation method that offers stable encapsulation of most drugs; each drug requires a different approach to manage all of its properties. Now is the time to combine all these strategies to achieve the goal of a complex, but successful, anticancer therapy.
Similar articles
-
The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo.J Control Release. 2010 Aug 17;146(1):68-75. doi: 10.1016/j.jconrel.2010.05.021. Epub 2010 May 24. J Control Release. 2010. PMID: 20510316
-
Entrapment of small molecules and nucleic acid-based drugs in liposomes.Methods Enzymol. 2005;391:7-40. doi: 10.1016/S0076-6879(05)91001-X. Methods Enzymol. 2005. PMID: 15721372
-
Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.Colloids Surf B Biointerfaces. 2014 Nov 1;123:345-63. doi: 10.1016/j.colsurfb.2014.09.029. Epub 2014 Sep 22. Colloids Surf B Biointerfaces. 2014. PMID: 25280609 Review.
-
Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.J Control Release. 2010 Jun 15;144(3):332-40. doi: 10.1016/j.jconrel.2010.02.029. Epub 2010 Mar 2. J Control Release. 2010. PMID: 20202473
-
Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.J Drug Target. 1994;2(5):449-54. doi: 10.3109/10611869408996821. J Drug Target. 1994. PMID: 7704490 Review.
Cited by
-
Current trends in the use of liposomes for tumor targeting.Nanomedicine (Lond). 2013 Sep;8(9):1509-28. doi: 10.2217/nnm.13.118. Nanomedicine (Lond). 2013. PMID: 23914966 Free PMC article. Review.
-
Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine.Biomolecules. 2019 Nov 23;9(12):773. doi: 10.3390/biom9120773. Biomolecules. 2019. PMID: 31771220 Free PMC article. Review.
-
Preparation, In-Vitro Characterization and Pharmacokinetic Evaluation of Brij Decorated Doxorubicin Liposomes as a Potential Nanocarrier for Cancer Therapy.Iran J Pharm Res. 2018;17(Suppl2):33-43. Iran J Pharm Res. 2018. PMID: 31011340 Free PMC article.
-
An update of advanced nanoplatforms for Glioblastoma Multiforme Management.EXCLI J. 2021 Nov 15;20:1544-1570. doi: 10.17179/excli2021-4393. eCollection 2021. EXCLI J. 2021. PMID: 34924904 Free PMC article. Review.
-
Immunological and Toxicological Considerations for the Design of Liposomes.Nanomaterials (Basel). 2020 Jan 22;10(2):190. doi: 10.3390/nano10020190. Nanomaterials (Basel). 2020. PMID: 31978968 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical